# "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures

> **NCT05523154** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Benign Pancreatic Neoplasm
- Malignant Pancreatic Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Laboratory Procedure
- **DEVICE:** Nanopore Sequencing

## Key facts

- **NCT ID:** NCT05523154
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-01-19
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-11-27
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** lack of funding
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523154, ""Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05523154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*